Page last updated: 2024-11-11

methyl 2,5-dihydroxycinnamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl 2,5-dihydroxycinnamate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,5-dihydroxycinnamic acid methyl ester : A cinnamate ester that is the methyl ester of 2,5-dihydroxycinnamic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5353609
CHEMBL ID17329
CHEBI ID84089
CHEBI ID93543
SCHEMBL ID343784
MeSH IDM0184923

Synonyms (52)

Synonym
BRD-K88741031-001-01-0
methyl (e)-3-(2,5-dihydroxyphenyl)prop-2-enoate
63177-57-1
2-propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester, (2e)-
K00021
BIOMOLKI2_000067
BIOMOLKI_000061
SMP2_000107
2,5-dihydroxycinnamic acid methyl ester, >=95%, crystalline
NCGC00024661-02
2,5-dihydroxycinnamic acid methyl ester
methyl 3-(2,5-dihydroxyphenyl)-2-propenoate
methyl 2,5-dihydroxycinnamate
2,4-dihydroxymethylcinnamate
2-propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester
HSCI1_000370
CHEMBL17329 ,
chebi:84089 ,
methyl 3-(2,5-dihydroxyphenyl)acrylate
BMK1-G1
methyl 3-(2,5-dihydroxyphenyl)prop-2-enoate
A834253
AKOS006271583
123064-80-2
CCG-100665
methyl (2e)-3-(2,5-dihydroxyphenyl)prop-2-enoate
BRD-K35573744-001-02-7
SCHEMBL343784
methyl grevillate
methyl 3-(2',5'dihydroxyphenyl)acrylate
methyl-2,5-dihydroxycinnamate
methyl (e)-3-(2,5-dihydroxyphenyl)acrylate
methyl (2e)-3-(2,5-dihydroxyphenyl)acrylate
BQCNSTFWSKOWMA-GORDUTHDSA-N
methyl 2,5-dihydoxycinnamate
mfcd00132932
SR-01000597715-1
sr-01000597715
bdbm50025624
CHEBI:93543
AS-59872
(e)-methyl 3-(2,5-dihydroxyphenyl)acrylate
Q27157467
3-(2,5-dihydroxy-phenyl)-acrylic acid methyl ester
F16667
HMS3675G10
BS-14687
HMS3411G10
AMY32369
CS-0166762
CS-0020685
HY-101006

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" By contrast, phenylephrine-induced dose-response curves in rabbit aorta were largely unaffected by tyrosine kinase inhibitors at 50 microM."( Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase.
Deth, RC; Jinsi, A, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitorAn EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cinnamate ester
hydroquinonesBenzenediols that have the hydroxy substituents in the 1- and 4-positions.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency50.11870.141337.9142100.0000AID1490
TDP1 proteinHomo sapiens (human)Potency0.94450.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency25.11890.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.18380.011212.4002100.0000AID1030
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency2.81840.035520.977089.1251AID504332
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (58)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1623873Reduction in ROS generation in human HaCaT cells assessed as decrease in DHE positive cells at 10 uM after 24 hrs by DHE-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623836Induction of apoptosis in human NCI-H460 cells assessed as late apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.93 +/- 0.04%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623866DNA protective activity in human NCI-H460 cells assessed as reduction in H2AX expression at 10 uM after 24 hrs by alexa fluor 488-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623838Induction of apoptosis in human NCI-H460/R cells transfected with MDR assessed as late apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.84 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623871Reduction in ROS generation in human NCI-H661 cells assessed as decrease in DHE positive cells at 10 uM after 24 hrs by DHE-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID202226Inhibitory concentration required against SW620 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623845Induction of apoptosis in human NCI-H460/R cells transfected with MDR assessed as necrotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 3.17 +/- 0.13%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID200813Inhibitory concentration required against SNB19 CNS cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623869Reduction in ROS generation in human NCI-H460 cells assessed as decrease in DHE positive cells at 10 uM after 24 hrs by DHE-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID274377Inhibition of human recombinant SIRT2 at 12.5 uM2006Journal of medicinal chemistry, Dec-14, Volume: 49, Issue:25
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
AID1623847Induction of apoptosis in human NCI-H661 cells assessed as necrotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 2.58 +/- 0.05%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID156018Inhibitory concentration required against PC-3 prostate cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID103423Inhibitory concentration required against MCF-7 breast cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID53779Inhibitory concentration required against DLD-1 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID358179Inhibition of EGFR1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID46278Inhibitory concentration required against COLO 205 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623816Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623867DNA protective activity in human HaCaT cells assessed as reduction in H2AX expression at 10 uM after 24 hrs by alexa fluor 488-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623822Induction of apoptosis in human NCI-H460 cells assessed as viable cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 96.49 +/- 0.96%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID9858Inhibitory concentration required against ACHN renal cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623870Reduction in ROS generation in human A549 cells assessed as decrease in DHE positive cells at 10 uM after 24 hrs by DHE-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623839Induction of apoptosis in human A549 cells assessed as late apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 1.54 +/- 0.03%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623826Induction of apoptosis in human NCI-H661 cells assessed as viable cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 96.16 +/- 0.96%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623846Induction of apoptosis in human A549 cells assessed as necrotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 1.52 +/- 0.05%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623872Reduction in ROS generation in human NCI-H460/R cells transfected with MDR assessed as reduction in DHE positive cells at 10 uM after 24 hrs by DHE-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID39252Inhibitory concentration against B16 murine melanoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623831Induction of apoptosis in human NCI-H460/R cells transfected with MDR assessed as early apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.22 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623817Cytotoxicity against human NCI-H661 cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623843Induction of apoptosis in human NCI-H460 cells assessed as necrotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 2.13 +/- 0.02%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID80256Inhibitory concentration against HCT 116 human colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623812Cytotoxicity against mouse L5178 cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID101799Inhibitory concentration required against MDA-MB-231 breast cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623814Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID80366Inhibitory concentration required against HCT 15 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID101007Inhibitory concentration required against LOX-IMVI melanoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623813Cytotoxicity against mouse L5178B1 cells transfected with pHa MDR1/A retrovirus assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623829Induction of apoptosis in human NCI-H460 cells assessed as early apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.45 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID79806Inhibitory concentration required against HCC2998 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID144956Inhibitory concentration required against NCI-H23 lung cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623824Induction of apoptosis in human NCI-H460/R cells transfected with MDR assessed as viable cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 95.76 +/- 2.87%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623825Induction of apoptosis in human A549 cells assessed as viable cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 96.45 +/- 2.89%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID85439Inhibitory concentration required against HT 29 colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623820Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623827Induction of apoptosis in human HaCaT cells assessed as viable cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 95.63 +/- 3.83%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623848Induction of apoptosis in human HaCaT cells assessed as necrotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 1.88 +/- 0.02%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623818Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID214782Inhibitory concentration required against UACC62 melanoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623841Induction of apoptosis in human HaCaT cells assessed as late apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 2.26 +/- 0.09%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623840Induction of apoptosis in human NCI-H661 cells assessed as late apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.95 +/- 0.03%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623834Induction of apoptosis in human HaCaT cells assessed as early apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.23 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623833Induction of apoptosis in human NCI-H661 cells assessed as early apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.31 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623815Cytotoxicity against human NCI-H460/R cells transfected with MDR assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID1623868DNA protective activity in human NCI-H460/R cells transfected with MDR assessed as increase in H2AX expression at 10 uM after 24 hrs by alexa fluor 488-staining based flow cytometry2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID8631Inhibitory concentration required against A 549 lung cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID8620Inhibitory concentration required against A 431 human epidermoid carcinoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1623832Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 10 uM after 24 hrs by Annexin V/propidium iodide-staining based flow cytometry (Rvb = 0.48 +/- 0.01%)2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's51 (85.00)18.2507
2000's6 (10.00)29.6817
2010's1 (1.67)24.3611
2020's2 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.25 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]